At a glance
ClinicalIndex Comparison RecordN/ACompleted· 171 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Medical Arm of the Interagency Registry for Mechanically Assisted Circulatory Support
National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted Aug 30, 2013·Updated Dec 6, 2018
In Brief
An observational study for Heart Failure and Systolic Heart Failure. Completed, enrolled 171 participants across 11 sites.
Detailed Summary
Medamacs is a prospective, observational study of ambulatory patients with advanced heart failure. The study enrolls patients who have not yet received a Left Ventricular Assist Device (LVAD) but who receive their care at a hospital with a Joint Commission certified mechanical circulatory support program. Medamacs is funded through the Interagency for Mechanically Assisted Circulatory Support (INTERMACS) NHLBI Contract.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure, Systolic Heart Failure
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2013
First PostedAug 2013
Primary CompletionJan 2017
TodayJul 2026
First PostedAug 30, 2013
Enrollment StartApr 1, 2013
Primary CompletionJan 20, 2017
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 12.8 years ago